I
493.35
7.51 (1.55%)
| Previous Close | 485.84 |
| Open | 482.40 |
| Volume | 1,581,463 |
| Avg. Volume (3M) | 1,919,676 |
| Market Cap | 175,203,500,032 |
| Price / Earnings (TTM) | 62.53 |
| Price / Earnings (Forward) | 49.26 |
| Price / Sales | 17.66 |
| Price / Book | 9.77 |
| 52 Weeks Range | |
| Earnings Date | 21 Apr 2026 |
| Profit Margin | 28.41% |
| Operating Margin (TTM) | 25.66% |
| Diluted EPS (TTM) | 6.81 |
| Quarterly Revenue Growth (YOY) | 19.20% |
| Quarterly Earnings Growth (YOY) | 28.20% |
| Total Debt/Equity (MRQ) | 0.88% |
| Current Ratio (MRQ) | 4.98 |
| Operating Cash Flow (TTM) | 2.73 B |
| Levered Free Cash Flow (TTM) | 1.66 B |
| Return on Assets (TTM) | 8.84% |
| Return on Equity (TTM) | 15.96% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Bearish | |
| Stock | Intuitive Surgical, Inc. | Bullish | Bearish |
AIStockmoo Score
0.3
| Analyst Consensus | 5.0 |
| Insider Activity | -3.5 |
| Price Volatility | 2.0 |
| Technical Moving Averages | -1.5 |
| Technical Oscillators | -0.5 |
| Average | 0.30 |
|
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Large Growth |
| % Held by Insiders | 0.52% |
| % Held by Institutions | 89.06% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 750.00 (Bernstein, 52.02%) | Buy |
| Median | 620.00 (25.67%) | |
| Low | 550.00 (Evercore ISI Group, 11.48%) | Hold |
| Average | 634.36 (28.58%) | |
| Total | 9 Buy, 2 Hold | |
| Avg. Price @ Call | 525.56 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Citigroup | 11 Mar 2026 | 590.00 (19.59%) | Buy | 493.56 |
| 23 Jan 2026 | 590.00 (19.59%) | Hold | 523.99 | |
| UBS | 24 Feb 2026 | 570.00 (15.54%) | Hold | 494.02 |
| Freedom Capital Markets | 27 Jan 2026 | 610.00 (23.64%) | Buy | 525.04 |
| TD Cowen | 27 Jan 2026 | 660.00 (33.78%) | Buy | 525.04 |
| Barclays | 26 Jan 2026 | 712.00 (44.32%) | Buy | 528.81 |
| 07 Jan 2026 | 686.00 (39.05%) | Buy | 592.27 | |
| BTIG | 23 Jan 2026 | 616.00 (24.86%) | Buy | 523.99 |
| 07 Jan 2026 | 616.00 (24.86%) | Buy | 592.27 | |
| Bernstein | 23 Jan 2026 | 750.00 (52.02%) | Buy | 523.99 |
| 09 Jan 2026 | 740.00 (49.99%) | Buy | 586.24 | |
| Evercore ISI Group | 23 Jan 2026 | 550.00 (11.48%) | Hold | 523.99 |
| Piper Sandler | 23 Jan 2026 | 620.00 (25.67%) | Buy | 523.99 |
| Truist Securities | 18 Dec 2025 | 650.00 (31.75%) | Buy | 561.89 |
| RBC Capital | 17 Dec 2025 | 650.00 (31.75%) | Buy | 556.86 |
| Show more | ||||
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BROSIUS MARK | - | 503.51 | -4,590 | -2,311,111 |
| CURET MYRIAM | - | 503.51 | -4,652 | -2,342,329 |
| Aggregate Net Quantity | -9,242 | |||
| Aggregate Net Value ($) | -4,653,439 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 503.51 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| CURET MYRIAM | Officer | 28 Feb 2026 | Disposed (-) | 4,652 | 503.51 | 2,342,329 |
| CURET MYRIAM | Officer | 28 Feb 2026 | Option execute | 9,380 | - | - |
| BROSIUS MARK | Officer | 28 Feb 2026 | Disposed (-) | 4,590 | 503.51 | 2,311,111 |
| BROSIUS MARK | Officer | 28 Feb 2026 | Option execute | 9,255 | - | - |
| Date | Type | Details |
|---|---|---|
| 26 Jan 2026 | Announcement | Da Vinci 5 Cleared for Cardiac Procedures |
| 23 Jan 2026 | Announcement | 20 Million Patients Benefit from da Vinci Surgery Globally |
| 22 Jan 2026 | Announcement | Intuitive Announces Fourth Quarter Earnings |
| 14 Jan 2026 | Announcement | Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |